Eriksen J, Kristensen P, Pyke C, Danø K
Finsen Laboratory, Rigshospitalet, Copenhagen, Denmark.
Histochemistry. 1989;92(5):377-83. doi: 10.1007/BF00492494.
Plasminogen activator inhibitor type-1 (PAI-1) was identified in extracts of rat adrenal medulla, and its immunohistochemical localization was studied together with that of tissue-type plasminogen activator (t-PA). By staining of adjacent sections and by double-staining of the same section we demonstrate that the same cells of the adrenal medulla contain both PAI-1 and t-PA immunoreactivity in the cytoplasm. In addition a few ganglion cells of the adrenal medulla were found to contain PAI-1 but not t-PA. Neither of the components were found in the adrenal cortex. Analysis of extracts from isolated adrenal medulla using reverse zymography showed the presence of a plasminogen activator inhibitor with Mr approximately 46,000. The inhibitory activity disappeared when the extract was passed through a column with sepharose-coupled anti-PAI-1 IgG, while the run-through from a similar column coupled with preimmune IgG still contained the inhibitor. The present findings suggest that PAI-1 could play a role in the regulation of t-PA activity in the rat adrenal gland medullary cells.
1型纤溶酶原激活物抑制剂(PAI-1)是在大鼠肾上腺髓质提取物中鉴定出来的,并且对其免疫组织化学定位以及组织型纤溶酶原激活物(t-PA)的免疫组织化学定位进行了研究。通过对相邻切片进行染色以及对同一切片进行双重染色,我们证明肾上腺髓质的相同细胞在细胞质中同时含有PAI-1和t-PA免疫反应性。此外,发现肾上腺髓质的一些神经节细胞含有PAI-1,但不含t-PA。肾上腺皮质中未发现这两种成分中的任何一种。使用反向酶谱法对分离的肾上腺髓质提取物进行分析,结果显示存在一种分子量约为46,000的纤溶酶原激活物抑制剂。当提取物通过与琼脂糖偶联的抗PAI-1 IgG柱时,抑制活性消失,而通过与免疫前IgG偶联的类似柱的流出物仍含有该抑制剂。目前的研究结果表明,PAI-1可能在大鼠肾上腺髓质细胞中t-PA活性的调节中发挥作用。